Lisi S.A. (LON:0EKE)
51.00
+0.60 (1.19%)
At close: Dec 17, 2025
Lisi S.A. Revenue
Lisi S.A. had revenue of 1.01B EUR in the half year ending June 30, 2025, with 20.06% growth. This brings the company's revenue in the last twelve months to 1.93B, up 9.43% year-over-year. In the year 2024, Lisi S.A. had annual revenue of 1.85B with 10.52% growth.
Revenue (ttm)
1.93B EUR
Revenue Growth
+9.43%
P/S Ratio
1.21
Revenue / Employee
188.48K EUR
Employees
10,262
Market Cap
2.01B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.85B | 176.48M | 10.52% |
| Dec 31, 2023 | 1.68B | 214.57M | 14.66% |
| Dec 31, 2022 | 1.46B | 264.33M | 22.04% |
| Dec 31, 2021 | 1.20B | -70.02M | -5.52% |
| Dec 31, 2020 | 1.27B | -488.57M | -27.79% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| Barclays | 26.02B |